[go: up one dir, main page]

LT3982960T - Paveldimos angioedemos gydymo būdai - Google Patents

Paveldimos angioedemos gydymo būdai

Info

Publication number
LT3982960T
LT3982960T LTEPPCT/GB2020/051439T LTGB2020051439T LT3982960T LT 3982960 T LT3982960 T LT 3982960T LT GB2020051439 T LTGB2020051439 T LT GB2020051439T LT 3982960 T LT3982960 T LT 3982960T
Authority
LT
Lithuania
Prior art keywords
treatment
methods
hereditary angioedema
angioedema
hereditary
Prior art date
Application number
LTEPPCT/GB2020/051439T
Other languages
English (en)
Inventor
Edward Paul FEENER
Sally Louise MARSH
Andreas MAETZEL
Michael David Smith
Christopher Martyn Yea
Original Assignee
Kalvista Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kalvista Pharmaceuticals Limited filed Critical Kalvista Pharmaceuticals Limited
Publication of LT3982960T publication Critical patent/LT3982960T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/GB2020/051439T 2019-06-14 2020-06-15 Paveldimos angioedemos gydymo būdai LT3982960T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962861725P 2019-06-14 2019-06-14
GBGB1910116.1A GB201910116D0 (en) 2019-07-15 2019-07-15 Treatments of hereditary angioedema
PCT/GB2020/051439 WO2020249977A1 (en) 2019-06-14 2020-06-15 Treatments of hereditary angioedema

Publications (1)

Publication Number Publication Date
LT3982960T true LT3982960T (lt) 2023-08-25

Family

ID=67700145

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/GB2020/051439T LT3982960T (lt) 2019-06-14 2020-06-15 Paveldimos angioedemos gydymo būdai

Country Status (32)

Country Link
US (1) US20220218680A1 (lt)
EP (2) EP3982960B1 (lt)
JP (2) JP7356518B2 (lt)
KR (1) KR102748728B1 (lt)
CN (1) CN114126612A (lt)
AR (1) AR119158A1 (lt)
AU (1) AU2020293614B2 (lt)
BR (1) BR112021024664A2 (lt)
CA (1) CA3142218A1 (lt)
CL (2) CL2021003244A1 (lt)
DK (1) DK3982960T3 (lt)
EA (1) EA202193019A1 (lt)
ES (1) ES2956471T3 (lt)
FI (1) FI3982960T3 (lt)
GB (1) GB201910116D0 (lt)
HR (1) HRP20230696T1 (lt)
HU (1) HUE063163T2 (lt)
IL (1) IL288615A (lt)
LT (1) LT3982960T (lt)
MA (1) MA56187B1 (lt)
MD (1) MD3982960T2 (lt)
MX (1) MX2021014557A (lt)
PH (1) PH12021552966A1 (lt)
PL (1) PL3982960T3 (lt)
PT (1) PT3982960T (lt)
RS (1) RS64412B1 (lt)
SG (1) SG11202113304YA (lt)
SI (1) SI3982960T1 (lt)
SM (1) SMT202300261T1 (lt)
TW (1) TW202112370A (lt)
WO (1) WO2020249977A1 (lt)
ZA (1) ZA202110685B (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201609607D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201719881D0 (en) 2017-11-29 2018-01-10 Kalvista Pharmaceuticals Ltd Solid forms of plasma kallikrein inhibitor and salts thereof
EP4010333A1 (en) 2019-08-09 2022-06-15 Kalvista Pharmaceuticals Limited Plasma kallikrein inhibitors
WO2022084693A1 (en) * 2020-10-23 2022-04-28 Kalvista Pharmaceuticals Limited Treatments of angioedema
US20240122909A1 (en) 2021-02-09 2024-04-18 Kalvista Pharmaceuticals Limited Treatments of hereditary angioedema
CN119095589A (zh) 2022-04-27 2024-12-06 卡尔维斯塔制药有限公司 血浆激肽释放酶抑制剂的制剂
CN116003386B (zh) * 2022-11-20 2024-03-26 药康众拓(北京)医药科技有限公司 一种氘代n-苄基吡啶酮吡唑甲酰胺类化合物、药物组合物和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
GB9019558D0 (en) 1990-09-07 1990-10-24 Szelke Michael Enzyme inhibitors
SE9301911D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptide derivatives
US5589467A (en) 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
GB0205527D0 (en) 2002-03-08 2002-04-24 Ferring Bv Inhibitors
US7429604B2 (en) 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
JP5322935B2 (ja) 2006-07-31 2013-10-23 アクティベサイト ファーマシューティカルズ インコーポレイティッド 血漿カリクレインの阻害薬
DE102006050672A1 (de) 2006-10-24 2008-04-30 Curacyte Discovery Gmbh Hemmstoffe des Plasmins und des Plasmakallikreins
JP2013121919A (ja) 2010-03-25 2013-06-20 Astellas Pharma Inc 血漿カリクレイン阻害剤
WO2012004678A2 (en) 2010-07-07 2012-01-12 The Medicines Company (Leipzig) Gmbh Serine protease inhibitors
US20130210809A1 (en) 2010-07-14 2013-08-15 Christelle Boléa Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
US9290485B2 (en) 2010-08-04 2016-03-22 Novartis Ag N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
GB2494851A (en) 2011-07-07 2013-03-27 Kalvista Pharmaceuticals Ltd Plasma kallikrein inhibitors
GB201300304D0 (en) 2013-01-08 2013-02-20 Kalvista Pharmaceuticals Ltd Benzylamine derivatives
KR102276700B1 (ko) 2013-05-23 2021-07-12 칼비스타 파마슈티컬즈 리미티드 헤테로사이클릭 유도체
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
GB201421083D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd Enzyme inhibitors
GB201721515D0 (en) * 2017-12-21 2018-02-07 Kalvista Pharmaceuticals Ltd Dosage forms comprising a plasma kallikrein inhibtor

Also Published As

Publication number Publication date
SG11202113304YA (en) 2021-12-30
TW202112370A (zh) 2021-04-01
DK3982960T3 (da) 2023-08-21
CL2023000639A1 (es) 2023-10-30
JP2023166406A (ja) 2023-11-21
WO2020249977A1 (en) 2020-12-17
PT3982960T (pt) 2023-09-26
ES2956471T3 (es) 2023-12-21
IL288615A (en) 2022-02-01
AR119158A1 (es) 2021-12-01
FI3982960T3 (fi) 2023-08-29
CA3142218A1 (en) 2020-12-17
KR20220024220A (ko) 2022-03-03
US20220218680A1 (en) 2022-07-14
EA202193019A1 (ru) 2022-03-24
PL3982960T3 (pl) 2024-01-15
HRP20230696T1 (hr) 2023-10-13
BR112021024664A2 (pt) 2022-05-31
HUE063163T2 (hu) 2023-12-28
RS64412B1 (sr) 2023-09-29
SMT202300261T1 (it) 2023-09-06
CN114126612A (zh) 2022-03-01
JP2022536287A (ja) 2022-08-15
ZA202110685B (en) 2024-06-26
JP7356518B2 (ja) 2023-10-04
MA56187B1 (fr) 2023-09-27
CL2021003244A1 (es) 2022-09-30
AU2020293614B2 (en) 2024-08-15
GB201910116D0 (en) 2019-08-28
EP3982960B1 (en) 2023-06-28
EP4282474A2 (en) 2023-11-29
AU2020293614A1 (en) 2022-01-27
KR102748728B1 (ko) 2024-12-30
PH12021552966A1 (en) 2022-07-25
SI3982960T1 (sl) 2023-10-30
MA56187A (fr) 2022-04-20
EP4282474A3 (en) 2024-02-14
MX2021014557A (es) 2022-01-11
EP3982960A1 (en) 2022-04-20
MD3982960T2 (ro) 2023-12-31

Similar Documents

Publication Publication Date Title
LT3982960T (lt) Paveldimos angioedemos gydymo būdai
IL282794A (en) Therapeutic methods
DK3173092T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3681500T3 (da) Anvendelse af pilocarpinhydrochlorid til behandling af presbyopi
IL288612A (en) Treatments for angioedema
IL257764B (en) Methods for treatment of diseases
IL282041A (en) Egfr inhibitors for treating keratodermas
IL281600A (en) Methods of treating cancer
IL281839A (en) Treatment methods
IL281792A (en) Treatment methods
IL287250A (en) treatment method
IL281284A (en) Methods of treating psoriasis
EP3578162A4 (en) HAIR TREATMENT METHOD
EP3972610A4 (en) MINI-GENE THERAPY
SG11202105877YA (en) Method of treatment
EP3706867A4 (en) POLYTHERAPIES FOR THE TREATMENT OF CEREBELLOUS ATAXIA
EP3758702A4 (en) TREATMENT OF HEREDITARY ANGIOEDEMA
GB201918853D0 (en) Methods of treatment
EP4072561A4 (en) Methods of treating cancer
EP3681495A4 (en) TREATMENT OF EXCITOTOXICITY
EP3577224A4 (en) NEW TREATMENT FOR NEAT1-ASSOCIATED ILLNESS
IL313079A (en) Methods of treatment using lou064
IL290983A (en) Treatment methods
HUE063820T2 (hu) Módszerek kardiovaszkuláris betegségek kezelésére
GB201900942D0 (en) Methods of treatment